(RTTNews) - Traws Pharma, Inc. (TRAW) announced the filing of a U.S. IND application with the FDA for tivoxavir marboxil, a potential CAP-dependent endonuclease inhibitor as a single oral tablet ...
FibroBiologics (FBLG) announced the filing of a Phase 1/2 Investigational New Drug application with the U.S. Food and Drug Administration seeking regulatory clearance to initiate clinical trials of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results